118 Results for "

3CLpro

" in MedChemExpress (MCE) Product Catalog:
Products (118)

118 Results for "3CLpro" in MCE Product Catalog:

Cat. No.: HY-17430S
CAS No.: 1217661-20-5
Amprenavir-d4 is the deuterium labeled Amprenavir. Amprenavir (VX-478) is a HIV protease inhibitor (Ki=0.6 nM) used to treat HIV infection. Amprenavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.09 μM .
loading...
    loading...
Cat. No.: HY-17430R
CAS No.: 161814-49-9
Synonyms: VX-478 (Standard)
Research Areas:  

Infection Cancer

Amprenavir (Standard) is the analytical standard of Amprenavir. This product is intended for research and analytical applications. Amprenavir (VX-478) is a HIV protease inhibitor (Ki=0.6 nM) used to treat HIV infection. Amprenavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.09 μM.
loading...
    loading...
Cat. No.: HY-160594
CAS No.: 890648-80-3
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

SARS 3CLpro-IN-2 (Example 9) is a severe acute respiratory syndrome 3C-like protease (SARS 3CL pro) inhibitor with an IC50 of 0.02 mM. It exhibits antiviral activity against SARS with an EC50 of 42 mM. SARS 3CLpro-IN-2 can be used in research related to severe acute respiratory syndrome .
loading...
    loading...
Cat. No.: HY-44484
CAS No.: 219929-01-8
Target:  

SARS-CoV

Research Areas:  

Infection

MAC-5576 is a SARS-CoV-2 3CL protease inhibitor, with an IC50 of 81 nM. MAC-5576 also inhibits 3CLpro (IC50=0.5 μM), HAV 3Cpro (IC50=0.5 μM), and thrombin (IC50=13 μM) .
loading...
    loading...
Cat. No.: HY-10237S
CAS No.: 1256751-11-7
Synonyms: EBP 520-d9; SCH 503034-d9
Boceprevir-d9 is the deuterium labeled Boceprevir. Boceprevir (EBP 520) is a potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with a Ki of 14 nM in both enzyme assay and an EC90 of 350 nM in cell-based replicon assay [3] . Boceprevir inhibits SARS-CoV-2 3CLpro activity .
loading...
    loading...
Cat. No.: HY-90001S3
CAS No.: 1217720-20-1
Synonyms: rel-ABT 538-d6; rel-RTV-d6
rel-Ritonavir-d6 (rel-ABT 538-d6) is the deuterium labeled rel-Ritonavir. rel-Ritonavir is a relative configuration of Ritonavir (HY-90001). Ritonavir (ABT 538) is an inhibitor of HIV protease used to study of HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM .
loading...
    loading...
Cat. No.: HY-10300R
CAS No.: 865466-24-6
Synonyms: SCH 900518 (Standard)
Research Areas:  

Infection

Narlaprevir (Standard) is the analytical standard of Narlaprevir. This product is intended for research and analytical applications. Narlaprevir (SCH 900518) is a selective and orally bioavailable NS3 protease inhibitor with a Ki value of 6 nM and an EC90 value of 40 nM . Narlaprevir also inhibits the HCV nonstructural protein 3 serine protease . Narlaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 2.3 μM [3].
loading...
    loading...
Cat. No.: HY-136606
CAS No.: 2413716-71-7
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV MPro-IN-1 is a SARS-CoV-2 3CLpro covalent inhibitor, with an IC50 of 40 nM. SARS-CoV MPro-IN-1 shows good anti-SARS-CoV-2-infection activity in cell culture with an EC50 of 0.33 μM. SARS-CoV MPro-IN-1 has the potential for COVID-19 research .
loading...
    loading...
Cat. No.: HY-17367S3
CAS No.: 1132747-14-8
Atazanavir-d5 is the deuterium labeled Atazanavir. Atazanavir (BMS-232632), a highly selective HIV-1 protease inhibitor, is the first protease inhibitor approved for once-daily administration . Atazanavir (BMS-232632) is a substrate and inhibitor of CYP3A4, and an inhibitor and inducer of P-glycoprotein (P-gp) . Atazanavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM [3].
loading...
    loading...
Cat. No.: HY-17367AR
CAS No.: 229975-97-7
Synonyms: BMS-232632 sulfate (Standard)
Atazanavir (sulfate) (Standard) is the analytical standard of Atazanavir (sulfate). This product is intended for research and analytical applications. Atazanavir (BMS-232632) sulfate, a highly selective HIV-1 protease inhibitor, is the first protease inhibitor approved for once-daily administration . Atazanavir sulfate is a substrate and inhibitor of CYP3A4, and an inhibitor and inducer of P-glycoprotein (P-gp) . Atazanavir sulfate is also a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM [3].
loading...
    loading...
Cat. No.: HY-10235R
CAS No.: 402957-28-2
Synonyms: VX-950 (Standard)
Research Areas:  

Infection

Telaprevir (Standard) is the analytical standard of Telaprevir. This product is intended for research and analytical applications. Telaprevir (VX-950) is a highly selective, reversible, and potent peptidomimetic inhibitor of the HCV NS3-4A protease, the steady-state inhibitory constant (Ki) of Telaprevir is 7 nM against a genotype 1 (H strain) NS3 protease domain plus a NS4A cofactor peptide [3]. Telaprevir inhibits SARS-CoV-2 3CLpro activity .
loading...
    loading...
Cat. No.: HY-169974
CAS No.: 3087307-24-9
SARS-CoV-2-IN-107 (Compound A7) is the inhibitor for SARS-CoV-2 3CLpro with an IC50 of 261.3 nM. SARS-CoV-2-IN-107 inhibits the SARS-CoV-2 replication with an EC50 of 11.7 μM. SARS-CoV-2-IN-107 exhibits anti-inflammatory activity with a NO inhibition rate of 68.6% in LPS (HY-D1056)-stimulated RAW264.7 macrophages .
loading...
    loading...
Cat. No.: HY-12594R
CAS No.: 1216941-48-8
Synonyms: ABT-450 (Standard); Veruprevir (Standard)
Research Areas:  

Infection

Paritaprevir (Standard) is the analytical standard of Paritaprevir. This product is intended for research and analytical applications. Paritaprevir (ABT-450) is a potent, orally active and antiviral non-structural protein 3/4A (NS3/4A) protease inhibitor with EC50s of 1 and 0.21 nM against HCV 1a and 1b, respectively. Paritaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.31 μM. Paritaprevir is metabolized primarily by cytochrome P450 (CYP) 3A. The plasma concentration and half-life of Paritaprevir can be enhanced by Ritonavir (a CYP450 inhibitor) [3] .
loading...
    loading...
Cat. No.: HY-184050
CAS No.: 1065478-52-5
Target:  

SARS-CoV

Research Areas:  

Infection

MERS-CoV-IN-3 is a 3CLpro inhibitor with an IC50 of 1.7 μM against MERS-CoV 3CLpro and an IC50 of 0.2 μM against SARS-CoV 3CLpro. MERS-CoV-IN-3 functionally inhibits protease activity essential for viral replication, downregulates viral protein production, reduces the secretion of infectious viral particles, and suppresses the replication of α-coronaviruses and β-coronaviruses derived from humans and cats. MERS-CoV-IN-3 can be used in studies related to coronavirus infections .
loading...
    loading...
Cat. No.: HY-183746
CAS No.: 128232-62-2
Research Areas:  

Infection

Catechin-5-O-gallate is a bioactive substance. Catechin-5-O-gallate can be isolated from bioactive Himalayan plants. Catechin-5-O-gallate is predicted to be a P-glycoprotein inhibitor, and binds to SARS-CoV-2 3CLpro, PLpro and RdRp. Catechin-5-O-gallate can be used in studies related to COVID-19 .
loading...
    loading...
Cat. No.: HY-183956
CAS No.: 2170616-59-6
Target:  

SARS-CoV

Research Areas:  

Infection

GC813 is a MERS-CoV 3CL protease (3CLpro) and MERS-CoV main protease (Mpro) inhibitor. GC813 can be used for the research of middle east respiratory syndrome .
loading...
    loading...
Cat. No.: HY-100721R
CAS No.: 1416992-39-6
Research Areas:  

Infection

GC376 (sodium) (Standard) is the analytical standard of GC376 (sodium) (HY-100721). This product is intended for research and analytical applications. GC376 sodium is a 3CLpro inhibitor; inhibits the replication of viruses TGEV, FIPV and PTV with IC50 values of 0.15, 0.2 and 0.15 μM, respectively.
loading...
    loading...
Cat. No.: HY-152589
CAS No.: 2761367-25-1
Target:  

SARS-CoV

Research Areas:  

Infection

Antiviral agent 25 (compound 6g) is a new non-peptide analog covalent inhibitor of SARS-CoV-2 3CL pro. Antiviral agent 25 has a strong inhibitory effect on SARS-CoV-2 3CL pro and SARS-CoV-2 PL pro with IC50 values of 0.118 µM, 0.448 µM, respectively. Antiviral agent 25 has antiviral effect on SARS-CoV-2 with an EC50 value of 7.249 µM .
loading...
    loading...
Cat. No.: HY-180318
CAS No.: 2698348-97-7
Target:  

SARS-CoV

Research Areas:  

Infection

MI-30 is an orally active SARS-CoV-2 3CLpro inhibitor (IC50 = 17.2 nM). MI-30 reduces viral load and lung lesions in a mouse model of SARS-CoV-2 infection. MI-30 may be used in coronavirus infection research .
loading...
    loading...
Cat. No.: HY-111074
CAS No.: 934017-32-0
Synonyms: MK-0767 analog
Target:  

SARS-CoV

Research Areas:  

Infection Metabolic Disease

DB12055 (MK-0767 analog) is a covalent SARS-CoV-2 3CL protease inhibitor. DB12055 has the potential for the study of dyslipidemia and diabetes mellitus .
loading...
    loading...